Clinical trials referral resource. Treatment of advanced colorectal cancer.
作者信息
Cheson B D
出版信息
Oncology (Williston Park). 1991 Apr;5(4):61-2, 65-6, 68 passim.
PMID:1831041
Abstract
摘要
相似文献
1
Clinical trials referral resource. Treatment of advanced colorectal cancer.
Oncology (Williston Park). 1991 Apr;5(4):61-2, 65-6, 68 passim.
2
How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.如何优化5-氟尿嘧啶调节疗法在晚期结直肠癌中的疗效。
Med Oncol. 1995 Sep;12(3):187-201. doi: 10.1007/BF01571196.
3
Metastatic colorectal cancer: advances in biochemical modulation and new drug development.
Semin Oncol. 1995 Oct;22(5):509-24.
4
Sparfosate. A novel biomodulator of 5-fluorouracil.
Cancer Pract. 1999 Jul-Aug;7(4):212-6. doi: 10.1046/j.1523-5394.1999.74011.x.
5
Biochemical modulation of 5-fluorouracil by PALA.
Cancer Invest. 1990;8(2):261-2. doi: 10.3109/07357909009017577.
6
Chemotherapy of advanced cancer of the colon and rectum.晚期结肠癌和直肠癌的化疗
Semin Oncol. 1991 Oct;18(5):443-61.
7
Recent advances in the treatment of advanced colorectal cancer.晚期结直肠癌治疗的最新进展
Cancer. 1993 Jan 1;71(1):9-18. doi: 10.1002/1097-0142(19930101)71:1<9::aid-cncr2820710104>3.0.co;2-y.
8
Biomodulation of Fluorouracil in colorectal cancer.氟尿嘧啶在结直肠癌中的生物调节作用。
Cancer Invest. 1998;16(4):237-51. doi: 10.3109/07357909809039773.
9
Biochemical modulation: a modality that has come of therapeutic age.
J Clin Oncol. 1991 Oct;9(10):1723-6. doi: 10.1200/JCO.1991.9.10.1723.
10
Phase I trial of PALA, methotrexate, fluorouracil, leucovorin, and uridine rescue in patients with advanced cancer. The use of uridine to decrease fluorouracil toxicity.
Cancer Invest. 1990;8(2):263-4. doi: 10.3109/07357909009017578.
Zotero 插件